anti-C-JUN (JUN) Antikörper

anti-Jun Proto-Oncogene Antikörper (JUN)
Auf finden Sie aktuell 876 Jun Proto-Oncogene (JUN) Antikörper von 34 unterschiedlichen Herstellern. Zusätzlich bieten wir Ihnen C-JUN Kits (102) und C-JUN Proteine (24) und viele weitere Produktgruppen zu diesem Protein an. Insgesamt sind aktuell 1063 C-JUN Produkte verfügbar.
AP-1, AP1, B230310J22Rik, Bsk, BSK/DJNK, c-jun, CG2275, CG5680, cJun, D-JNK, d-JRA, d-jun, D-jun/Jra, D-junk, dAP-1, DBSK/JNK, dJNK, DJNK/bsk, dJra, djun, dm-Jun, Dmel\\CG2275, Dmel\\CG5680, fj36h07, jnk, JNK/SAPK, jra, jun, Junc, Junk, l(2)46Ef, l(2)IA109, l(2R)IA109, p39, SAPKa, V, wu:fj36h07, zgc:65863

Alle verfügbaren anti-C-JUN Antikörper

Sie gelangen zu unserer vorgefilterten Suche.

Am meisten referenzierte anti-C-JUN Antikörper

  1. Human Polyclonal C-JUN Primary Antibody für IHC, ELISA - ABIN1531886 : Binétruy, Smeal, Karin: Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain. in Nature 1991 (PubMed)
    Zeige alle 4 Referenzen für 1531886

  2. Human Polyclonal C-JUN Primary Antibody für DB, IHC (p) - ABIN389544 : Fang, Kerppola: Ubiquitin-mediated fluorescence complementation reveals that Jun ubiquitinated by Itch/AIP4 is localized to lysosomes. in Proceedings of the National Academy of Sciences of the United States of America 2004 (PubMed)
    Zeige alle 2 Referenzen für 389544

  3. Cow (Bovine) Polyclonal C-JUN Primary Antibody für ChIP, IHC - ABIN2792650 : Adiseshaiah, Li, Vaz, Kalvakolanu, Reddy: ERK signaling regulates tumor promoter induced c-Jun recruitment at the Fra-1 promoter. in Biochemical and biophysical research communications 2008 (PubMed)
    Zeige alle 2 Referenzen für 2792650

  4. Human Polyclonal C-JUN Primary Antibody für DB - ABIN389696 : Wang, Li, Qi, Yuan, Ai, Zhu, Cao, Yang, Liu, Wu, Liu: TRIM45, a novel human RBCC/TRIM protein, inhibits transcriptional activities of ElK-1 and AP-1. in Biochemical and biophysical research communications 2004 (PubMed)
    Zeige alle 2 Referenzen für 389696

  5. Human Polyclonal C-JUN Primary Antibody für FACS, IHC (p) - ABIN650689 : Song, Han, Sabapathy, Lee, Yu, Choi: Expression of a homeostatic regulator, Wip1 (wild-type p53-induced phosphatase), is temporally induced by c-Jun and p53 in response to UV irradiation. in The Journal of biological chemistry 2010 (PubMed)
    Zeige alle 2 Referenzen für 650689

  6. Cow (Bovine) Polyclonal C-JUN Primary Antibody für WB - ABIN2774668 : Trøen, Nygaard, Jenssen, Ikonomou, Tierens, Matutes, Gruszka-Westwood, Catovsky, Myklebost, Lauritzsen, Hovig, Delabie: Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma. in The Journal of molecular diagnostics : JMD 2004 (PubMed)

  7. Cow (Bovine) Polyclonal C-JUN Primary Antibody für WB - ABIN2780411 : Grau, Punzón, Fresno, Iñiguez: Peroxisome-proliferator-activated receptor alpha agonists inhibit cyclo-oxygenase 2 and vascular endothelial growth factor transcriptional activation in human colorectal carcinoma cells via inhibition of activator protein-1. in The Biochemical journal 2006 (PubMed)

Weitere Antikörper gegen C-JUN Interaktionspartner

Xenopus laevis Jun Proto-Oncogene (JUN) Interaktionspartner

  1. AP-1(c-Jun/FosB (zeige FOSB Antikörper)) may play a role in neurogenesis via the induction of FoxD5b expression during early vertebrate development

  2. The cJun transcription factor bound to a variant cAMP response element in the promoter region of tlx3 (zeige TLX3 Antikörper) and modulated transcription and regulated neurotransmitter phenotype via its transactivation domain

Fruit Fly (Drosophila melanogaster) Jun Proto-Oncogene (JUN) Interaktionspartner

  1. Mir (zeige MYLIP Antikörper)-8 modulates Drosophila C virus replication by negative regulation of dJun.

  2. Here we uncover a cell non-autonomous requirement for the Epidermal growth factor receptor (Egfr (zeige EGFR Antikörper)) pathway in the lateral epidermis for sustained dpp (zeige TGFb Antikörper) expression in the LE. Specifically, we demonstrate that Egfr (zeige EGFR Antikörper) pathway activity in the lateral epidermis prevents expression of the gene scarface (scaf), encoding a secreted antagonist of JNK (zeige MAPK8 Antikörper) signaling

  3. Tau and spectraplakin promote synapse formation and maintenance through Jun kinase (zeige MAPK9 Antikörper) and neuronal trafficking.

  4. n addition to significantly increasing the number of JNK (zeige MAPK8 Antikörper) target genes identified so far, our results reveal that the LE is a highly heterogeneous morphogenetic organizer, sculpted through crosstalk between JNK (zeige MAPK8 Antikörper), segmental and AP signalling. This fine-tuning regulatory mechanism is essential to coordinate morphogenesis and dynamics of tissue sealing

  5. malignant transformation of the ras(V12)scrib(1 (zeige SCRIB Antikörper)) tumors requires bZIP protein Fos, the ETS (zeige ETS1 Antikörper)-domain factor Ets21c and the nuclear receptor Ftz-F1 (zeige NR5A2 Antikörper), all acting downstream of Jun-N-terminal kinase (zeige MAPK8 Antikörper).

  6. Diminished MTORC1-dependent JNK (zeige MAPK8 Antikörper) activation underlies the neurodevelopmental defects associated with lysosomal dysfunction.

  7. ROS (zeige ROS1 Antikörper)/JNK (zeige MAPK8 Antikörper)/p38 (zeige MAPK14 Antikörper)/Upd (zeige UROD Antikörper) stress responsive module restores tissue homeostasis. This module is not only activated after cell death induction but also after physical damage and reveals one of the earliest responses for imaginal disc regeneration.

  8. Significantly, the JNK (zeige MAPK8 Antikörper) pathway is responsible for the majority of the phenotypes and transcriptional changes downstream of Notch (zeige NOTCH1 Antikörper)-Src (zeige SRC Antikörper) synergy.

  9. This study demonstrated that the mechanism by which Bsk (zeige FRK Antikörper) is required for pruning is through reducing the membrane levels of the adhesion molecule (zeige NCAM1 Antikörper) Fasciclin II (zeige NCAM2 Antikörper) (FasII)

  10. Jra recruits the HP1a (zeige CBX5 Antikörper)/KDM4A (zeige KDM4A Antikörper) complex to its gene body region upon osmotic stress to reduce H3K36 methylation levels and disrupt H3K36 methylation-dependent histone deacetylation

Pig (Porcine) Jun Proto-Oncogene (JUN) Interaktionspartner

  1. Porcine reproductive and respiratory syndrome virus -activated TAK-1 (zeige NR2C2 Antikörper) was essential for the activation of JNK (zeige MAPK8 Antikörper) and NF-kappaB (zeige NFKB1 Antikörper) pathways and IL-8 (zeige IL8 Antikörper) expression.

  2. The effects of prostaglandin F2alpha administration on transcription factor AP-1 expression and the expression of downstream genes involved in luteolysis are reported.

Rabbit Jun Proto-Oncogene (JUN) Interaktionspartner

  1. ICAM1 (zeige ICAM1 Antikörper) and IL10 (zeige IL10 Antikörper) were upregulated in ventilator-induced lung injury. Nuclear transcription factor AP-1 may be responsible for this upregulation.

Mouse (Murine) Jun Proto-Oncogene (JUN) Interaktionspartner

  1. AP1 factors are important regulators of adult taste cell renewal and their downregulation negatively impacts taste maintenance.

  2. these data indicate that MEF2 (zeige MEF2C Antikörper) and AP-1 confer antagonistic regulation of Hspb7 (zeige HSPB7 Antikörper) gene expression in skeletal muscle, with implications for autophagy and muscle atrophy.

  3. results suggest that fibroblasts, c-Jun, and IGF-1 (zeige IGF1 Antikörper) play key roles in mediating stromal-epithelial interactions that are required for the therapeutic effects of finasteride in benign prostate epithelial cells

  4. These findings highlight a key role of the TLR4 (zeige TLR4 Antikörper)-NOS1 (zeige NOS1 Antikörper)-AP1 signaling axis in regulating macrophage polarization

  5. Data suggest that Sf1 and c-jun interact and cooperate to activate the Fdx1 promoter in MA-10 (tumorigenic cell line) and TM3 (non-tumorigenic cell line) Leydig cells; such activation requires different regulatory elements located between -124 and -306 bp of Fdx1 promoter and involves recruitment of Sf1 to this region. (Sf1 = splicing factor 1; c-jun = proto-oncogene c-jun; Fdx1 = ferredoxin 1)

  6. In this study, we discovered that selective upregulation of p39 (zeige ATP6V0D1 Antikörper) is the underlying mechanism that accommodates the increased functional requirement of Cdk5 (zeige CDK5 Antikörper) activation during neuronal differentiation. In addition, we demonstrated that p39 (zeige ATP6V0D1 Antikörper) selectively directs Cdk5 (zeige CDK5 Antikörper) to phosphorylate protein substrates essential for axonal development, dendritic spine formation, and synaptogenesis. Moreover, our studies suggest opposing roles o

  7. NF-kappaB (zeige NFKB1 Antikörper) and c-Jun coregulate lipopolysaccharide-induced Fra-1 (zeige FOSL1 Antikörper) transcription.

  8. BATF/JUN-B and BATF/C-JUN complexes play important roles in OA cartilage destruction through regulating anabolic and catabolic gene expression in chondrocytes.

  9. this study shows that c-Jun regulates the activation state of macrophages and promotes arthritis via differentially regulating cyclooxygenase-2 (zeige PTGS2 Antikörper) and arginase-1 (zeige ARG1 Antikörper) levels

  10. PLIO treatment inhibited nuclear factorkappaB (NFkappaB) nuclear translocation in B16F10 cells. In addition, PLIO treatment inhibited the phosphorylation of c-Jun Nterminal kinases and AKT (zeige AKT1 Antikörper)

Human Jun Proto-Oncogene (JUN) Interaktionspartner

  1. Our results indicate that assessing AP1 (zeige FOSB Antikörper) and PEA3 (zeige ETV4 Antikörper) transcription factor status might be a good indicator of OAC status. However, we could not detect any associations with disease stage or patient treatment regime. This suggests that the PEA3 (zeige ETV4 Antikörper)-AP1 (zeige FOSB Antikörper) regulatory module more likely contributes more generally to the cancer phenotype. In keeping with this observation, depletion of ETV1 (zeige ETV1 Antikörper) and/or ETV4 (zeige ETV4 Antikörper) causes an OAC cell growth defect

  2. shRNA-mediated inhibition of JUN decreases AML (zeige RUNX1 Antikörper) cell survival and propagation in vivo. These data uncover a previously unrecognized role of JUN as a regulator of the unfolded protein response

  3. These findings demonstrate an essential role for the ERK pathway together with c-JUN and c-FOS in the differentiation activity of LukS-PV.

  4. The present study defines the minimal TIM-3 (zeige HAVCR2 Antikörper) promoter region and demonstrates its interaction with c-Jun during TIM-3 (zeige HAVCR2 Antikörper) transcription in CD4 (zeige CD4 Antikörper)(+) T cells.

  5. Taken together, our data demonstrate that JNK (zeige MAPK8 Antikörper) regulates triple-negative breast cancer (TNBC)tumorigenesis by promoting CSC phenotype through Notch1 (zeige NOTCH1 Antikörper) signaling via activation of c-Jun and indicate that JNK/c-Jun/Notch1 (zeige NOTCH1 Antikörper) signaling is a potential therapeutic target for TNBC

  6. Regulation of osteosarcoma cell lung metastasis by the c-Fos/AP-1 target FGFR1

  7. c-jun promoted FOXK1 (zeige FOXK2 Antikörper)-mediated proliferation and metastasis via orthotopic implantation.

  8. Data provide evidence that AP-1 (zeige FOSB Antikörper) is a key determinant of endocrine resistance of breast cancer cells by mediating a global shift in the estrogen receptor (zeige ESR1 Antikörper) transcriptional program.

  9. Comparison of how AP-1 (Jun/Jun dimer) and Epstein-Barr virus Zta recognize methyl groups within their cognate response elements

  10. this study revealed the functional and mechanistic links between CDK5 (zeige CDK5 Antikörper) and the oncogenic ERK5 (zeige MAPK7 Antikörper)-AP-1 (zeige FOSB Antikörper) signaling pathway in the pathogenesis of colorectal cancer.

Zebrafish Jun Proto-Oncogene (JUN) Interaktionspartner

  1. These results support a role for trim69 (zeige TRIM69 Antikörper) in the development of the zebrafish brain through ap-1 pathway.

  2. CPEB-1 (zeige CPEB1 Antikörper) control of c-Jun mRNA translation regulates GH gene expression and resulting downstream signaling events (e.g., synaptic plasticity) in the mouse hippocampus.

Cow (Bovine) Jun Proto-Oncogene (JUN) Interaktionspartner

  1. The present data indicate that bovine dialyzable leukocyte extract can block the AP-1 DNA-binding activity and expression of several transcriptions factors in breast cancer cells.

  2. dynamic compression stimulates cell proliferation and proteoglycan (zeige Vcan Antikörper) synthesis in the presence of IL-1beta (zeige IL1B Antikörper) and/or inhibitors of the MAPKs and NFkappaB and AP-1 signalling pathways

C-JUN (JUN) Antigen-Profil

Beschreibung des Gens

This gene is the putative transforming gene of avian sarcoma virus 17. It encodes a protein which is highly similar to the viral protein, and which interacts directly with specific target DNA sequences to regulate gene expression. This gene is intronless and is mapped to 1p32-p31, a chromosomal region involved in both translocations and deletions in human malignancies.

Alternative names and synonyms associated with C-JUN (JUN)

  • jun oncogene (jun) Antikörper
  • basket (bsk) Antikörper
  • C-JUN protein (C-JUN) Antikörper
  • c-Jun protein (C-JUN) Antikörper
  • c-jun transcription factor (C-JUN) Antikörper
  • cyclin-dependent kinase 5, regulatory subunit 2 (p39) (Cdk5r2) Antikörper
  • Jun oncogene (Jun) Antikörper
  • jun proto-oncogene (JUN) Antikörper
  • jun proto-oncogene (jun) Antikörper
  • jun proto-oncogene (Jun) Antikörper
  • Jun-related antigen (Jra) Antikörper
  • AP-1 Antikörper
  • AP1 Antikörper
  • B230310J22Rik Antikörper
  • Bsk Antikörper
  • BSK/DJNK Antikörper
  • c-jun Antikörper
  • CG2275 Antikörper
  • CG5680 Antikörper
  • cJun Antikörper
  • D-JNK Antikörper
  • d-JRA Antikörper
  • d-jun Antikörper
  • D-jun/Jra Antikörper
  • D-junk Antikörper
  • dAP-1 Antikörper
  • DBSK/JNK Antikörper
  • dJNK Antikörper
  • DJNK/bsk Antikörper
  • dJra Antikörper
  • djun Antikörper
  • dm-Jun Antikörper
  • Dmel\\CG2275 Antikörper
  • Dmel\\CG5680 Antikörper
  • fj36h07 Antikörper
  • jnk Antikörper
  • JNK/SAPK Antikörper
  • jra Antikörper
  • jun Antikörper
  • Junc Antikörper
  • Junk Antikörper
  • l(2)46Ef Antikörper
  • l(2)IA109 Antikörper
  • l(2R)IA109 Antikörper
  • p39 Antikörper
  • SAPKa Antikörper
  • V Antikörper
  • wu:fj36h07 Antikörper
  • zgc:65863 Antikörper

Bezeichner auf Proteinebene für JUN

v-jun sarcoma virus 17 oncogene homolog , CG5680-PB , CG5680-PE , CG5680-PF , JNK , JUN kinase , Jun N-terminal kinase , Jun NH2-terminal kinase , Jun-N-terminal kinase , Jun-kinase , bsk-PB , bsk-PE , bsk-PF , c-Jun N-terminal kinase , c-Jun aminoterminal kinase , c-Jun-N-terminal kinase , drosophila JNK , AP1 , V-jun avian sarcoma virus 17 oncogene homolog , activator protein 1 , proto-oncogene c-jun , transcription factor AP-1 , CDK5 activator 2 , cyclin-dependent kinase 5 activator 2 , cyclin-dependent kinase 5 regulatory subunit 2 , p39I , AH119 , immediate early , jun A , Jun activation domain binding protein , enhancer-binding protein AP1 , jun oncogene , p39 , proto-oncogene c-Jun , v-jun avian sarcoma virus 17 oncogene homolog , Avian sarcoma virus 17 (v-jun) oncogene homolog , Jun oncogene , v-jun sarcoma virus 17 oncogene , CG2275-PA , CG2275-PB , CG2275-PC , Jra-PA , Jra-PB , Jra-PC , Jun related antigen , complementation group V , lethal(2)1A109 , lethal(2)IA109

379050 Xenopus laevis
44801 Drosophila melanogaster
396913 Sus scrofa
443219 Ovis aries
100008856 Oryctolagus cuniculus
12570 Mus musculus
16476 Mus musculus
3725 Homo sapiens
335916 Danio rerio
24516 Rattus norvegicus
399400 Xenopus laevis
424673 Gallus gallus
609429 Canis lupus familiaris
280831 Bos taurus
100170668 Ovis aries
36057 Drosophila melanogaster
Ausgewählte Anbieter für anti-C-JUN (JUN) Antikörper
Haben Sie etwas anderes gesucht?